Literature DB >> 22100894

Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1.

Anita E Popko-Scibor1, Mikael J Lindberg, Magnus L Hansson, Teresa Holmlund, Annika E Wallberg.   

Abstract

Earlier studies demonstrated the involvement of the p300 histone acetyltransferase in Notch signaling but the precise mechanisms by which p300 might modulate Notch function remains to be investigated. In this study, we show that p300 acetylates Notch1 ICD in cell culture assay and in vitro, and conserved lysines located within the Notch C-terminal nuclear localization signal are essential for Notch acetylation. MAML1 and CSL, which are components of the Notch transcription complex, enhance Notch acetylation and we suggest that MAML1 increases Notch acetylation by potentiating p300 autoacetylation. Furthermore, MAML1-dependent acetylation of Notch1 ICD by p300 decreases the ubiquitination of Notch1 ICD in cellular assays. CDK8 has been shown to target Notch1 for ubiquitination and proteosomal degradation. We show that CDK8 inhibits Notch acetylation and Notch transcription enhanced by p300. Therefore, we speculate that acetylation of Notch1 might be a mechanism to regulate Notch activity by interfering with ubiquitin-dependent pathways.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100894     DOI: 10.1016/j.bbrc.2011.11.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer.

Authors:  Angela N Flores; Niamh McDermott; Armelle Meunier; Laure Marignol
Journal:  Nat Rev Urol       Date:  2014-08-19       Impact factor: 14.432

Review 2.  The role of Notch receptors in transcriptional regulation.

Authors:  Hongfang Wang; Chongzhi Zang; X Shirley Liu; Jon C Aster
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

Review 3.  Roles of Notch Signaling in the Tumor Microenvironment.

Authors:  Antonino B D'Assoro; Roberto Leon-Ferre; Eike-Benjamin Braune; Urban Lendahl
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 4.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

5.  MAML1 acts cooperatively with EGR1 to activate EGR1-regulated promoters: implications for nephrogenesis and the development of renal cancer.

Authors:  Magnus L Hansson; Stefanie Behmer; Rebecca Ceder; Sadollah Mohammadi; Giulio Preta; Roland C Grafström; Bengt Fadeel; Annika E Wallberg
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

6.  C-terminal deletion of NOTCH1 intracellular domain (N1ICD) increases its stability but does not amplify and recapitulate N1ICD-dependent signalling.

Authors:  Jennifer Blain; Jessily Bédard; Maureen Thompson; François-Michel Boisvert; Marie-Josée Boucher
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

7.  Nucleolar localization of the Notch4 intracellular domain underpins its regulation of the cellular response to genotoxic stressors.

Authors:  Neetu Saini; Apurva Sarin
Journal:  Cell Death Discov       Date:  2020-02-18

Review 8.  Decoding the PTM-switchboard of Notch.

Authors:  Daniel Antfolk; Christian Antila; Kati Kemppainen; Sebastian K-J Landor; Cecilia Sahlgren
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-07-11       Impact factor: 4.739

9.  Mastermind-Like 1 Is Ubiquitinated: Functional Consequences for Notch Signaling.

Authors:  Mozhgan Farshbaf; Mikael J Lindberg; Anh Truong; Zachery Bevens; Elaina Chambers; Angeliki Pournara; Annika E Wallberg; J Brandon White
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

Review 10.  Notch Signaling in Neuroendocrine Tumors.

Authors:  Judy S Crabtree; Ciera S Singleton; Lucio Miele
Journal:  Front Oncol       Date:  2016-04-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.